跳至主要内容
临床试验/NL-OMON38471
NL-OMON38471已完成不适用

Coagulation and fibrinolysis in patients with resistance to thyroid hormone due to a thyroid hormone receptor β-gene mutation - The THRβ study

Academisch Medisch Centrum0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with thyroid hormone resistance due to a mutation in the thyroid hormone receptor beta gene
  • - Elevated T3 and/or T4 according to the local reference ranges;For the control groups:
  • a) hyperthyroid patients with elevated serum T4 and/or T3 according to the local reference ranges
  • b) euthyroid controls with general good health, both matched for age (± 5 years) and gender

排除标准

  • - No informed consent
  • - Oral anticoagulant therapy (warfarin, vitamin K antagonists)
  • - Hemophilia or von Willebrand's disease
  • - Oral corticosteroid therapy
  • - Previous VTE within the last 6 months
  • - Previous thyroid surgery or radio-iodine treatment
  • - Current anti-thyroid drugs

研究者

相似试验

Coagulation and fibrinolysis in patients with... | 临床试验